A Validated Stability Indicating RP-HPLC Method for the Determination of Emtricitabine, Tenofovir Disoproxil Fumarate, Elvitegravir and Cobicistat in Pharmaceutical Dosage Form
- PMID: 26865655
- PMCID: PMC4890450
- DOI: 10.1093/chromsci/bmw004
A Validated Stability Indicating RP-HPLC Method for the Determination of Emtricitabine, Tenofovir Disoproxil Fumarate, Elvitegravir and Cobicistat in Pharmaceutical Dosage Form
Abstract
A new simple, rapid stability indicating assay method has been developed and validated for the determination of emtricitabine, tenofovir disoproxil fumarate, elvitegravir and cobicistat using reverse-phase high-performance liquid chromatography in their pharmaceutical dosage form. The chromatographic separation was performed on an ODS column (250 × 4.6 mm, 5 µm) using mobile phase A (potassium dihydrogen orthophosphate, pH adjusted to 2.5) and mobile phase B (acetonitrile) in the ratio of 55:45% v/v at a flow rate of 1 mL/min. The analytes were detected at 250 nm. The method was found to be linear in the concentration range of 2-12 µg/mL for EMT, 3-18 µg/mL for TNDF, 1.5-9 µg/mL for ELV and COB, with the coefficient value (R(2)) of >0.9990. The accuracy was measured via recovery studies and found to be acceptable, and the percentage recoveries were found in the range of 99.93-100.08 ± 0.5%. Forced degradation studies were also conducted, and the drugs were subjected to various stress conditions such as acid hydrolysis, base hydrolysis, oxidative, photolytic and thermal degradation. The proposed method was successfully validated and applied for the quantitative estimation of these drugs in both bulk and tablet dosage forms.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Figures
References
-
- Bang L.M., Scott L.J.; Emtricitabine and antiretroviral agent for HIV infections; Drugs, (2003); 63: 2413–2424. - PubMed
-
- Saag M.S.; Emtricitabine, a new antiviral agent with activity against HIV and Hepatitis B virus; Reviews of Anti-Infective Agents, (2006); 42: 126–131. - PubMed
-
- Budawari S.; The Merck Index. 13th ed Merck and Co. Inc., Whitehouse Station, NJ, (2001); pp. 1631–1632.
-
- Martindale W.; Martindale: TheComplete DrugReference, 33rd edn. Pharmaceutical Press, London, (2002); pp. 620–642.
-
- Fung H.B., Stone E.A., Piacenti F.J.; Tenofovir disoproxil fumarate: a nucleoside reverse transcriptase inhibitor for the treatment of HIV infections; Clinical Therapeutics, (2002); 24: 1515–1548. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
